New York, NY, United States of America

W Vallen Graham

This inventor holds 1 USPTO granted patent. Top assignee: The Rockefeller University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: W Vallen Graham. Retrieved from https://idiyas.com/inventor/w-vallen-graham

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: W Vallen Graham: Innovator in Amyloid Research

Introduction

W Vallen Graham is a notable inventor based in New York, NY (US). He has made significant contributions to the field of amyloid research, particularly in the development of antibodies that target amyloid protofibrils. His work has implications for diagnosing and treating amyloid diseases, which are associated with various neurodegenerative conditions.

Latest Patents

W Vallen Graham holds a patent for "Amyloid protofibril antibodies and methods of use thereof." This invention relates to methods for obtaining antibodies that recognize amyloid protofibrils. It also includes methods for using these antibodies to prevent or inhibit amyloid disease in a subject, diagnose amyloid disease, and detect amyloid protofibrils in a sample. He has 1 patent to his name.

Career Highlights

Graham is affiliated with The Rockefeller University, where he conducts his research. His work is pivotal in advancing our understanding of amyloid diseases and developing potential therapeutic strategies.

Collaborations

One of his notable collaborators is Thomas P Sakmar, with whom he has likely shared insights and research efforts in the field of amyloid research.

Conclusion

W Vallen Graham's innovative work in amyloid research highlights the importance of targeted therapies in combating amyloid diseases. His contributions are paving the way for future advancements in this critical area of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…